Exercise and geriatric assessment for older adults with colorectal cancer
Tests exercise and geriatric assessment for dizziness and walking problems in older colorectal cancer patients.
Plain-language title generated from the registry record
Registry title: The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer
Key facts
- Where
- Copenhagen and Herlev, DenmarkSee the 2 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 65 or older who are getting chemotherapy for colorectal cancer. It tests a geriatric check-up and group exercise against muscle weakness, dizziness and balance problems.
- Age
- 65 years or older
- Sex
- All sexes can join.
- Disease stage
- Colorectal cancer treated with chemotherapy before surgery, after surgery, or as first treatment for advanced disease. Daily activity level (ECOG performance status) of 2 or lower.
- Earlier treatment
- People who had chemotherapy within two years and still have nerve damage, dizziness, vertigo or balance problems cannot join.
Main reasons for not taking part
- Chemotherapy within two years with lasting nerve damage, dizziness, vertigo or balance problems
- Severe physical disability that prevents exercise
- Dementia, psychotic disorders or other cognitive conditions that prevent taking part
- Cannot sign the informed consent form
- Visit to the geriatric outpatient clinic in the past six months
Read by machine on 9 November 2026.
Where in Denmark
- Copenhagen University Hospital, RigshospitaletCopenhagen, DenmarkNot yet recruiting
- Copenhagen University Hospital - Herlev and Gentofte HospitalHerlev, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Copenhagen University Hospital, Rigshospitalet
- Trial code
- NCT05710809
- Record updated
- 6 April 2025
- Original description
The goal of this clinical trial is to learn about the cause of dizziness and decline in walking ability in in older adults ≥65 years during chemotherapy treatment for colorectal cancer. Another goal is to investigate if a comprehensive geriatric assessment and three months' specialized physical group-based exercise three times/week can counteract muscle weakness, vertigo, instability, impaired walking balance, and neuropathyRead full original descriptionShow less
The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer
The goal of this clinical trial is to learn about the cause of dizziness and decline in walking ability in in older adults ≥65 years during chemotherapy treatment for colorectal cancer. Another goal is to investigate if a comprehensive geriatric assessment and three months' specialized physical group-based exercise three times/week can counteract muscle weakness, vertigo, instability, impaired walking balance, and neuropathy
Inclusion: Meet the criteria of the oncological departments of receiving neoadjuvant, adjuvant or first line palliative chemotherapy for colorectal cancer; ≥65 years of age at the time of signing the informed consent form; Able to speak and read Danish, and to provide a signed informed consent form; Have an Eastern Cooperative Oncology Group (ECOG) performance status score of ≤2.
Exclusion: Chemotherapy treatment within two years and sequelae of neuropathy, or symptoms of dizziness or vertigo, or balance disturbance; Dementia, psychotic disorders, or other cognitive diseases or conditions that hinder participation in a clinical exercise-based trial; Severe physical disability that hinders physical exercise; Inability to sign informed content; Patients who have had a consultation in the geriatric outpatient clinic within the past six months.